TESTING PANELS

 

Pan Retinal Disorders Panel (161 genes)

The Pan Retinal Disorders Panel is a comprehensive next-generation sequencing (NGS) panel that can be used to confirm a clinical diagnosis of an inherited retinal disorder or identify at-risk individuals.


Achromatopsia Panel (6 genes)

The Achromatopsia Panel is a comprehensive next-generation sequencing (NGS) panel that can be used to confirm a clinical diagnosis of achromatopsia or identify at-risk individuals.


Bardet-Biedl Syndrome Panel (19 genes)

The Bardet-Biedl Panel is a comprehensive next-generation sequencing (NGS) panel that can be used to confirm a clinical diagnosis of Bardet-Biedl syndrome or identify at-risk individuals.


Cone-Rod Dystrophy Panel (30 genes)

The Cone-Rod Dystrophy Panel is a comprehensive next-generation sequencing (NGS) panel that can be used to confirm a clinical diagnosis of cone-rody dystrophy or identify at-risk individuals.


Congenital Cataracts Panel (44 genes)

The Congenital Cataracts Panel is a comprehensive next-generation sequencing (NGS) panel that can be used to confirm a clinical diagnosis of congenital cataracts or identify at-risk individuals.


Congenital Stationary Night Blindness Panel (18 genes)

The Congenital Stationary Night Blindness Panel is a comprehensive next-generation sequencing (NGS) panel that can be used to confirm a clinical diagnosis of congenital stationary night blindness or identify at- risk individuals.


Corneal Dystrophies Panel (8 genes)

The Corneal Dystrophies Panel is a comprehensive next-generation sequencing (NGS) panel that can be used to confirm a clinical diagnosis of corneal dystrophy or identify at-risk individuals.


Early-Onset Glaucoma Panel (12 genes)

The Early-Onset Glaucoma Panel is a comprehensive next-generation sequencing (NGS) panel that can be used to confirm a clinical diagnosis of early-onset glaucoma or identify at-risk individuals.


Leber Congenital Amaurosis Panel (25 genes)

The Leber Congenital Amaurosis Panel is a comprehensive next-generation sequencing (NGS) panel that can be used to confirm a clinical diagnosis of Leber congenital amaurosis or identify at-risk individuals.


Macular Dystrophy Panel (24 genes)

The Macular Dystrophy Panel is a comprehensive next-generation sequencing (NGS) panel that can be used to confirm a clinical diagnosis of macular dystrophy or identify at-risk individuals.


Retinitis Pigmentosa Panel (83 genes)

The Retinitis Pigmentosa Panel is a comprehensive next-generation sequencing (NGS) panel that can be used to confirm a clinical diagnosis of retinitis pigmentosa or identify at-risk individuals.


Usher Syndrome Panel (13 genes)

The Usher Syndrome Panel is a comprehensive next-generation sequencing (NGS) panel that can be used to confirm a clinical diagnosis of Usher syndrome or identify at-risk individuals.